argenx (NasdaqGS:ARGX) Q3 2025 Earnings Call October 30, 2025 08:30 AM ET Company ParticipantsDanielle Brill - Managing DirectorAlex Thompson - Research Managing Director and Biotech Equity ResearchTim Van Hauwermeiren - CEOLuc Truyen - Chief Medical OfficerRajan Sharma - Executive Director and Pharma and Biotech Equity ResearchKaren Massey - COOCassie Yuan - Equity Research AssociateBeth DelGiacco - VP of Corporate Communications and Investor RelationsDouglas Tsao - Managing DirectorAmy Li - SVP of Equity ...